AI assistant
Sending…
IONIS PHARMACEUTICALS INC — Director's Dealing 2012
Sep 6, 2012
30591_dirs_2012-09-06_4fa22e7b-89f7-4d60-8a4e-ff7eff05ce96.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2012-09-04
Reporting Person: PARSHALL B LYNNE (Director, COO, Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-04 | Common Stock | M | 10000 | $5.25 | Acquired | 11985 | Direct |
| 2012-09-04 | Common Stock | S | 10000 | $15.001 | Disposed | 1985 | Direct |
| 2012-09-04 | Common Stock | M | 10000 | $5.25 | Acquired | 10000 | Indirect |
| 2012-09-04 | Common Stock | S | 10000 | $15.001 | Disposed | 0 | Indirect |
| 2012-09-04 | Common Stock | M | 10000 | $5.25 | Acquired | 10000 | Indirect |
| 2012-09-04 | Common Stock | S | 10000 | $15.001 | Disposed | 0 | Indirect |
| 2012-09-05 | Common Stock | M | 2000 | $5.25 | Acquired | 3985 | Direct |
| 2012-09-05 | Common Stock | S | 2000 | $15.00 | Disposed | 1985 | Direct |
| 2012-09-06 | Common Stock | M | 2494 | $6.84 | Acquired | 4479 | Direct |
| 2012-09-06 | Common Stock | S | 2494 | $15.035 | Disposed | 1985 | Direct |
| 2012-09-06 | Common Stock | M | 2506 | $5.25 | Acquired | 4491 | Direct |
| 2012-09-06 | Common Stock | S | 2506 | $15.035 | Disposed | 1985 | Direct |
| 2012-09-06 | Common Stock | M | 5000 | $5.25 | Acquired | 6985 | Direct |
| 2012-09-06 | Common Stock | S | 5000 | $15.002 | Disposed | 1985 | Direct |
| 2012-09-06 | Common Stock | M | 5000 | $6.84 | Acquired | 5000 | Indirect |
| 2012-09-06 | Common Stock | S | 5000 | $15.035 | Disposed | 0 | Indirect |
| 2012-09-06 | Common Stock | M | 5000 | $5.25 | Acquired | 5000 | Indirect |
| 2012-09-06 | Common Stock | S | 5000 | $15.002 | Disposed | 0 | Indirect |
| 2012-09-06 | Common Stock | M | 5000 | $6.84 | Acquired | 5000 | Indirect |
| 2012-09-06 | Common Stock | S | 5000 | $15.035 | Disposed | 0 | Indirect |
| 2012-09-06 | Common Stock | M | 5000 | $5.25 | Acquired | 5000 | Indirect |
| 2012-09-06 | Common Stock | S | 5000 | $15.002 | Disposed | 0 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-09-04 | Employee Stock Option (right to buy) | $5.25 | M | 10000 | Disposed | 2013-01-02 | Common Stock (10000) | Direct |
| 2012-09-04 | Employee Stock Option (right to buy) | $5.25 | M | 10000 | Disposed | 2013-01-02 | Common Stock (10000) | Indirect |
| 2012-09-04 | Employee Stock Option (right to buy) | $5.25 | M | 10000 | Disposed | 2013-01-02 | Common Stock (10000) | Indirect |
| 2012-09-05 | Employee Stock Option (right to buy) | $5.25 | M | 2000 | Disposed | 2013-01-02 | Common Stock (2000) | Direct |
| 2012-09-06 | Employee Stock Option (right to buy) | $5.25 | M | 7506 | Disposed | 2013-01-02 | Common Stock (7506) | Direct |
| 2012-09-06 | Employee Stock Option (right to uy) | $6.84 | M | 2494 | Disposed | 2013-01-01 | Common Stock (2494) | Direct |
| 2012-09-06 | Employee Stock Option (right to buy) | $5.25 | M | 5000 | Disposed | 2013-01-02 | Common Stock (5000) | Indirect |
| 2012-09-06 | Employee Stock Option (right to buy) | $5.25 | M | 5000 | Disposed | 2013-01-02 | Common Stock (5000) | Indirect |
| 2012-09-06 | Employee Stock Option (right to buy) | $6.84 | M | 5000 | Disposed | 2013-01-01 | Common Stock (5000) | Indirect |
| 2012-09-06 | Employee Stock Option (right to buy) | $6.84 | M | 5000 | Disposed | 2013-01-01 | Common Stock (5000) | Indirect |
Footnotes
F1: Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 1/16/2012.
F2: Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person's daughter on 1/16/2012.
More from IONIS PHARMACEUTICALS INC
Board/Management Information
2026
Jun 8
Regulatory Filings
2026
May 28
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Earnings Release
2026
Apr 29
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Mar 27